Orapred ODT Alternatives Compared
| Orapred ODT (prednisolone) | Rebif (interferon beta-1a) | Copaxone (glatiramer) |
|
|---|
| Orapred ODT (prednisolone) | Rebif (interferon beta-1a) | Copaxone (glatiramer) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Asthma - acute, Bronchopulmonary Dysplasia, Bullous Pemphigoid, Dermatitis, Crohn's Disease - Active, Immunosuppression, Infantile Spasms, Inflammatory Conditions, Multiple Sclerosis... View more |
Prescription only
Rebif may be used to reduce the frequency of exacerbations of MS and delay the progression of the disease in adults. It is usually self-administered by SC injection three times per week and the most... View more |
Prescription only
Copaxone is a combination of four amino acids that may be given to treat relapsing forms of multiple sclerosis in adults. It has been shown to significantly reduce the number of relapses but may be... View more |
||||||||||||||||||||||||
| More about Orapred ODT (prednisolone) | More about Rebif (interferon beta-1a) | More about Copaxone (glatiramer) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Rebif has an average rating of 6.9 out of 10 from a total of 29 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 21% reported a negative effect. |
Copaxone has an average rating of 7.6 out of 10 from a total of 133 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Orapred ODT prices |
View all Rebif prices |
View all Copaxone prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other prednisolone brands include: Millipred, Millipred DP, PediaPred | Other interferon beta-1a brands include: Avonex, Avonex Pen, Avonex Prefilled Syringe, Rebif Rebidose | Other glatiramer brands include: Glatopa | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
4 hours |
3 hours |
1 hour |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 605 drugs are known to interact with Orapred ODT:
|
A total of 337 drugs are known to interact with Rebif:
|
A total of 1 drugs are known to interact with Copaxone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
June 01, 2006 |
March 07, 2002 |
December 20, 1996 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.